Sign up
Pharma Capital
EPIC: ATE
Market: TSX-V:ATE
OTCMKTS:ATBPF
52-week High/Low: C$0.46 / C$0.24
Sector: Health Care, Equipment & Services
Market Cap: C$77.79M
Website: antibethera.com

Antibe Therapeutics is a publicly-traded biotechnology company pursuing a breakthrough advance in the treatment and prevention of inflammation. Antibe's drug pipeline addresses a $20+ billion market in non-addictive pain management, cardiovascular disease, and cancer prevention. Antibe’s lead drug, now in late Phase 2 trials, is demonstrating unprecedented safety and efficacy in the...

Antibe Therapeutics

antibethera.com

Interactive graph

col 3
col 4
col 5
col 6

Big picture - Why invest in Antibe Therapeutics

View full ATE profile View Profile
View All

Market Reports Including ATE

VIEW ALL

Executive video interviews

VIEW ALL VIDEOS

© biotech Capital 2019

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.